Adverse event [GxP / QC / QA]

posted by Bhavesh – India, 2009-08-17 09:41 (6147 d 08:25 ago) – Posting: # 4050
Views: 7,112

Dear KK,

I agree with you but confusion arise during report preparation. Under which treatment I shall consider it. because we specify AE in percentage respective of treatment and based on that final conclusion will drawn.

Bhavesh Shah


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
129 visitors (0 registered, 129 guests [including 13 identified bots]).
Forum time: 18:06 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5